trending Market Intelligence /marketintelligence/en/news-insights/trending/jLIBSNBjW9Yr06jvLq2REw2 content esgSubNav
In This List

Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management


Corindus Vascular stockholders approve $1.1B acquisition by Siemens Healthineers

Corindus Vascular Robotics Inc. stockholders approved Siemens Healthineers AG's $1.1 billion acquisition of the company.

The Waltham, Mass.-based maker of robotic-assisted systems said stockholders also approved certain compensation to be paid to some of its executives in connection with the merger.

Germany's Siemens Healthineers announced the acquisition in August, agreeing to pay in cash $4.28 apiece for Corindus common stock and $85.60 apiece for series A and series A-1 preferred stocks.

Corindus will be delisted from the NYSE American once the transaction closes Oct. 29.

Citigroup Global Markets Inc. and Cadwalader Wickersham & Taft LLP advised Corindus on the deal.